TABLE 2.
Distribution of GSK656 MICs among NTM isolates
| Species | No. of strains with MIC (mg/liter) of: |
Total no. | MIC50 (mg/liter)a | MIC90 (mg/liter) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <0.008 | 0.008 | 0.016 | 0.031 | 0.063 | 0.125 | 0.25 | 0.5 | 1.0 | 2.0 | 4.0 | 8.0 | >8.0 | ||||
| M. intracellulare | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 28 | 30 | >8.0 | >8.0 |
| M. avium | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 16 | >8.0 | >8.0 |
| M. abscessus | 0 | 0 | 1 | 18 | 14 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 36 | 0.031 | 0.063 |
a
MIC50, concentration required to inhibit the growth of 50% of the isolates tested; MIC90, concentration required to inhibit the growth of 90% of the isolates tested.